Major Depressive Disorder (MDD) in Children and Adolescents
The prevalence of MDD in children and adolescents is notable. The most recent data shows that 41.7 percent of adolescents aged 12–17 years received treatment for major depressive episodes throughout 2018, while suicide is among the leading causes of death for children and adolescents with an estimated 2.4 suicide attempts per 100 children ages 14–18. There is a great need for health care providers (HCPs) to adopt a proactive, preventive approach to evaluation and treatment for this population. This activity will present HCPs with a comprehensive overview of MDD and suicidality in children and adolescents, and effective screening tools will be reviewed. The focus of MDD will include subtypes, differential diagnoses, risk factors, protective factors, and the course of illness that may be expected. Aspects of suicidality such as current statistics, risk assessment, and prevention will be discussed. Importantly, treatment modalities will be examined, with an updated overview of effective antidepressant medications and psychological therapies.
This activity is jointly provided by OptumHealth Education and Optum Behavioral Health.
There was no commercial support received for this activity.
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
This activity is designed to meet the educational needs of physicians, nurses, psychologists, social workers, counselors, and therapists who are interested in learning about pertinent topics in behavioral health, including current trends, concerns, data, and influencing factors surrounding mental health outcomes.
At the end of this educational activity, participants should be able to:
- Identify the features of Major Depressive Disorder (MDD) in children and adolescents, including subtypes, risk factors, protective factors, and the course of illness.
- Recognize the differential diagnoses for MDD that should be considered.
- Discuss suicide in children and adolescents, including statistics, risk factors, warning signs, and suicide prevention.
- Review current anti-depressant medications prescribed for children and adolescents with MDD.
Minta Pamela Spain, MD
NY Behavioral Health Medical Director
UnitedHealthcare Community Plan
Elizabeth V. Albert, MD
Clinical Activity Manager
LaRhonda Jones, MD
ECS-Senior Behavioral Medical Director – Central Region
Disclosures of relevant financial relationships
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education (OHE) requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or his/her spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest. OHE ensures that the content is independent of commercial bias.
The activity faculty or planners have no financial relationships to disclose.
In support of improving patient care, this activity has been planned and implemented by OptumHealth Education and Optum Behavioral Health. OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit designation statements
The participant will be awarded up to 1.00 contact hour(s) of credit for attendance and completion of supplemental materials.
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
OptumHealth Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
OptumHealth Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. OptumHealth Education maintains responsibility for this program. 1.00 CE hour.
As a Jointly Accredited Organization, OptumHealth Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. OptumHealth Education maintains responsibility for this course. Social workers completing this course receive 1.00 live continuing education credits.
Counselors and/or marriage and family therapists
CA: The Board of Behavioral Sciences has deferred CE course approvals to APA and ASWB for its licensees. See those approvals under Psychologists and Social Workers.
Other States: If your state is not specifically listed, nearly all state Counselor and MFT boards accept either APA or ASWB approval, or are reciprocal with other state licensing board approvals, such as those listed below. Check with your board to be sure.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization from which they wish to obtain credit.
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
Activity date/time: This live activity will be held on Wednesday, April 21, 2021 from 11:00 am - 12:00 pm CT (12-1 pm ET; 10-11 am MT; 9-10 am PT).
WebEx link for Wednesday, April 21, 2021: https://optum.webex.com/optum/j.php?MTID=m399ddf5fd8aac9bea1ca32138a34dd47
- Meeting number (access code): 185 201 3242
- Meeting password: utCsCXJ?586
YOUR PHONE LINE WILL BE MUTED UPON YOUR ENTRY INTO THE WEBEX. Please keep your phone muted throughout the activity.
Q&A: If you would like to ask the speaker a question during the live activity, please write your question in the WebEx chat box and select "Everyone" prior to pressing send.
Please allow yourself enough time to test your computer before the start of the activity.
Fees: There are no fees for participating in or receiving credit for this activity.
Questions: Email email@example.com